humanitarian Archived signal RAW fallback · translation pending

Human medicines European public assessment report (EPAR): Rasonque, Daraxonrasib, Status: Opinion

Human medicines European public assessment report (EPAR): Daybu, trofinetide, Date of authorisation: 20/08/2026, Revision: 1, Status: Authorised

Reported by EMA What Is New Oct 15, 2026 · 13:35 UTC

Read the complete report at EMA What Is New ↗

Verification notice

IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.

INCIDENT FUSION

10 reports · 2 sources

EMA What Is NewHuman medicines European public assessment report (EPAR): Rasonque, Daraxonrasib, Status: Opinion13:35 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Rasonque, Daraxonrasib, Status: Opinion13:35 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Cabometyx, cabozantinib, Date of authorisation: 09/09/2016, Revision: 21, Status: Authorised12:42 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Cabometyx, cabozantinib, Date of authorisation: 09/09/2016, Revision: 21, Status: Authorised12:42 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Nexviadyme, avalglucosidase alfa, Date of authorisation: 24/06/2022, Revision: 7, Status: Authorised12:40 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Nexviadyme, avalglucosidase alfa, Date of authorisation: 24/06/2022, Revision: 7, Status: Authorised12:40 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Koselugo, selumetinib, Date of authorisation: 17/06/2021, Revision: 10, Status: Authorised10:00 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Koselugo, selumetinib, Date of authorisation: 17/06/2021, Revision: 10, Status: Authorised10:00 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Opuviz, aflibercept, Date of authorisation: 13/11/2024, Revision: 5, Status: Authorised08:36 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Opuviz, aflibercept, Date of authorisation: 13/11/2024, Revision: 5, Status: Authorised08:36 UTC

INCIDENT EVOLUTION

2 recorded states

Oct 15 · 13:56 UTC

Signal first indexedP2 · 99% quality · 2 sources

Oct 15 · 14:00 UTC

Headline updatedP2 · 99% quality · 2 sources

Explore this day in the archive →